Status:
COMPLETED
Daily Delivery and Supervision of Psychotropic Medication for High-Risk Patients With Severe/Persistent Mental Illness
Lead Sponsor:
University of Manitoba
Collaborating Sponsors:
Winnipeg Regional Health Authority
Conditions:
Medication Adherence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main study intervention is the daily witnessing of participant self-administration of medications by trained pharmacy staff to ensure compliance. The staff in question will be provided by Leila ph...
Detailed Description
The program is designed to serve individuals with severe and persistent mental illnesses who have been repeatedly hospitalized, are repeat users of community crisis services, or are frequently in cont...
Eligibility Criteria
Inclusion
- Individuals currently enrolled in the new daily dispensing program
- Individuals with severe and persistent mental illnesses
- Individuals who have been repeatedly hospitalized, are repeat users of community crisis services, or are in frequently in contact with the criminal justice system
- Individuals who are involved in the Forensics program.
Exclusion
- Individuals who are not currently in the Forensics program
- Individuals who are part of the daily dispensing program, but are not Forensic outpatients
Key Trial Info
Start Date :
October 15 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 11 2019
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT03766503
Start Date
October 15 2016
End Date
February 11 2019
Last Update
June 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Manitoba
Winnipeg, Canada